Welcome to our dedicated page for Hippo Hldgs SEC filings (Ticker: HIPOW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The HIPPO HOLDINGS INC WTS (HIPOW) SEC filings page provides access to regulatory documents connected to Hippo Holdings Inc., the underlying issuer whose common stock trades on the New York Stock Exchange under the symbol HIPO. Because HIPOW represents warrants linked to Hippo Holdings Inc., the company’s SEC reports are a primary source of information for understanding developments that may matter to holders of the warrants.
In a Form 8-K, Hippo Holdings Inc. discloses material events such as changes in the size of its Board of Directors, the appointment of new directors, and their assignments to key committees including the Audit, Risk, and Compliance Committee, the Nominating & Corporate Governance Committee, and the Compensation Committee. The filing also outlines the Non-Employee Director Compensation Program, describing annual cash retainers and restricted stock unit (RSU) awards valued based on the average closing trading price of the company’s common stock and subject to vesting conditions.
On this page, users can review filings like Form 8-K to see how Hippo Holdings Inc. reports governance changes, equity-based compensation practices, and other significant corporate actions. Real-time updates from the SEC’s EDGAR system allow investors to track new disclosures as they are filed, while AI-powered summaries help explain the contents of lengthy documents in more accessible language.
In addition to current reports on Form 8-K, this page can surface other key filing types for Hippo Holdings Inc., such as annual and quarterly reports when available, as well as information related to equity awards and potential change-in-control provisions described in the company’s incentive plans. For HIPOW warrant holders, these filings provide important context about the corporate environment and reporting practices of the underlying issuer.
Thomas B. Akin and related entities filed an amended Schedule 13G reporting beneficial ownership of 2,888,370 shares of Hippo Holdings Inc. common stock, or 11.4% of the class. This percentage is based on 25,335,179 shares outstanding as of October 29, 2025.
Within this group, Thomas B. Akin directly beneficially owns 1,479,262 shares, Talkot Fund LP owns 988,109 shares, Blair Spencer Akin owns 140,000 shares, Akin Family Foundation owns 125,000 shares, Karen Hochster owns 105,999 shares, and Kyle Akin owns 50,000 shares. The filers certify the shares are not held to change or influence control of Hippo.
Hippo Holdings Inc. Chief Executive Officer and director Richard McCathron sold 5,000 shares of common stock on February 9, 2026 in an open-market transaction at $29.14 per share, executed under a Rule 10b5-1 trading plan dated August 29, 2025.
After this sale, McCathron beneficially owned 442,704 shares of Hippo Holdings Inc. common stock, including 181,675 restricted stock units (RSUs), all reported as held directly.
Hippo Holdings Inc. insider Richard McCathron filed a Rule 144 notice to sell 5,000 shares of common stock through Merrill Lynch on or about 02/09/2026 on the NYSE, with an aggregate market value of $145,700.
These shares come from restricted stock units acquired between 2020 and 2022. The notice also reports prior sales over the last three months: 5,000 common shares on 12/09/2025 for gross proceeds of $149,100 and 5,000 common shares on 01/09/2026 for gross proceeds of $157,600. Hippo had 25,335,179 common shares outstanding when this notice was prepared.
BlackRock, Inc. disclosed that it beneficially owns 1,268,932 shares of Hippo Holdings Inc. common stock, representing 5.00% of the class as of 12/31/2025. BlackRock reports sole voting power over 1,240,640 shares and sole dispositive power over the full 1,268,932 shares, with no shared voting or dispositive authority.
The filing is made on a Schedule 13G basis, indicating the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Hippo Holdings. Various underlying clients and accounts have rights to dividends or sale proceeds, but no single client has more than five percent of Hippo’s outstanding common shares.
Hippo Holdings Inc. Chief Executive Officer and director Richard McCathron reported selling 5,000 shares of common stock on January 9, 2026 at $31.52 per share in an open-market transaction coded as a sale.
After this transaction, he beneficially owned 447,704 shares of Hippo common stock, including 181,675 restricted stock units (RSUs). The filing notes that the sale was carried out under a pre-established Rule 10b5-1 trading plan dated August 29, 2025, indicating the trades were scheduled in advance.
Hippo Holdings Inc. received a notice that an individual security holder plans to sell 5,000 shares of its common stock under Rule 144. The shares were originally acquired as 5,000 restricted stock units from Hippo Holdings Inc. on 12/24/2020. The planned sale is to be executed through Merrill Lynch on the NYSE around 01/09/2026, with an indicated aggregate market value of $157,600 and with 25,335,179 common shares outstanding. The form also reports that the same seller disposed of 5,000 common shares on 12/09/2025 for gross proceeds of $149,100 during the prior three months.
An insider of the company with ticker HIPO has filed a notice to sell 3,900 shares of its common stock through broker Morgan Stanley Smith Barney LLC on the NYSE. The planned sale has an aggregate market value of $120,471.00, compared with 25,335,179 shares outstanding of the same class. The securities to be sold were acquired from the issuer as restricted stock units and performance stock units on 08/15/2025 and 09/10/2025, in amounts of 2,627 and 1,273 shares respectively, with payment noted as non-cash. The filer represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
Hippo Holdings Inc. director reports charitable stock gift
A director of Hippo Holdings Inc. reported donating 4,935 shares of common stock on 12/18/2025 in a transaction coded as a gift at a price of $0.00 per share. After this donation, the director beneficially owns 16,563 shares of common stock directly, including 4,738 restricted stock units, and 50,000 shares indirectly through Janajasa Associates L.P. The filing reflects a personal charitable transfer rather than an open-market sale.
Hippo Holdings Inc. insider activity: Chief Executive Officer and director Richard McCathron reported selling 5,000 shares of Hippo common stock on 12/09/2025 at a price of $29.82 per share. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan dated August 29, 2025, which is designed to allow insiders to sell shares according to a preset schedule. Following this transaction, McCathron beneficially owns 452,704 shares of Hippo common stock, which includes 181,675 restricted stock units (RSUs).
Hippo Holdings Inc. has a planned sale of restricted stock reported under Rule 144. The notice covers up to 5,000 shares of common stock to be sold through Merrill Lynch on the NYSE, with an aggregate market value of
The filing states that 25,335,179 shares of the issuer’s common stock were outstanding, providing context on the size of the planned sale relative to the overall share base. The approximate sale date listed is
FAQ
What is the current stock price of Hippo Hldgs (HIPOW)?
